
Alan has over 16 years experience in the Pharmaceutical Industry. His roles included Sales & Marketing, Senior Management, Account Management and Business Development for Major organisations including GSK and AZ. He also worked for Takeda as one of their Regional Account Directors in their innovative approach to the NHS in the UK.
His practical experience extends across many disciplines including Coaching and Mentoring, Change Management, Sales Force Effectiveness ,Commercial Excellence and Key Account Management.
He worked in the UK and Internationally where he had Leadership and Management Responsibility for more than 250 staff as well as full P&L responsibility for his Business.
His company L2L Group provides Consulting and Training Services to the Pharmaceutical Industry Globally. He has worked across most major markets in Europe as well as China, the Middle East and Africa. Contact : info@L2LGroup.com
It is an increasingly common question being asked or investigated within the majority of Pharmaceutical companies these days.The intriguing question is what is the driver behind the foc
(Aug 18, 2009)Firstly an apology or two, the title was in no way directed at you the reader or indeed anyone else specifically, secondly I apologise for another blog that plagarises recent US presidential Campai
(Sep 15, 2009)For many years, the main approach to selling pharmaceuticals was geared around a Share of Voice Model, which focused on frequency and coverage as the main drivers of sales.
(Oct 8, 2009)The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs